Form 8-K - Current report:
SEC Accession No. 0001104659-25-066306
Filing Date
2025-07-08
Accepted
2025-07-08 09:23:38
Documents
14
Period of Report
2025-07-08
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2520065d1_8k.htm   iXBRL 8-K 48529
2 EXHIBIT 3.1 tm2520065d1_ex3-1.htm EX-3.1 13828
3 EXHIBIT 3.2 tm2520065d1_ex3-2.htm EX-3.2 78362
  Complete submission text file 0001104659-25-066306.txt   337107

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA akya-20250708.xsd EX-101.SCH 3014
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE akya-20250708_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akya-20250708_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2520065d1_8k_htm.xml XML 3925
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

EIN.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40344 | Film No.: 251109696
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)